Skip to main content
Article thumbnail
Location of Repository

The Role of Protein Kinase B and Mitochondrial Permeability Transition Pore in Ischaemic Preconditioning of Myocardium

By Mohammad Ali Husainy


Background:\ud Protein kinase B (PKB) plays a critical role in cell survival, growth and proliferation. The investigation of its involvement has been limited by the lack of specific pharmacological agents. Similarly mitochondrial permeability transition pore (MPTP) plays a critical role in necrotic and apoptotic cell death. Opposed role of MPTP (transient versus sustained opening) in cardioprotection has been proposed. Therefore the primary aims of this thesis were to (i) to investigate the influence of PKB in the tolerance to ischaemia/reoxygenation (I/R), (ii) to define the relationship of PKB with the mitoKATP channel and with p38 MAPK in the signal transduction mechanism of cardioprotection by IP, (iii) to determine how two structurally different MPTP inhibitors (Cyclosporine A and Bongkrekic Acid) administered for varying time regimes influenced ischemia/reperfusion (I/R)-induced injury and (iv) to explore how pharmacologic MPTP opening at different time points during I/R modulated myocardial injury.\ud Methods & Results:\ud Myocardial slices from rat left ventricle and from the right atrial appendage of patients undergoing elective cardiac surgery were subjected to 90 min ischaemia/120 min reoxygenation at 37◦C. Tissue injury was assessed by creatine kinase (CK) released and determination of cell necrosis and apoptosis. Myocardial caspase 3 was also assessed. Muscles were randomized to receive various treatments. The results showed that blockade of PKB activity caused significant reduction of CK release and cell death, a benefit that was as potent as ischaemic preconditioning and could be reproduced by blockade of phosphatidylinositol 3-kinase (PI-3K) with wortmannin and LY 294002. The protection was time dependent with maximal benefit seen when PKB and PI-3K were inhibited before ischaemia or during both ischaemia and reoxygenation. PKB inhibition induced a similar degree of protection in the human and rat myocardium and, importantly, it reversed the unresponsiveness to protection of the diabetic myocardium. The status of MPTP can dramatically influence ischemic/reoxygenation-induced injury and protection of the rat left ventricular myocardium. Importantly, the status of the MPTP during first 10 min of reoxygenation is of critical importance with both opening and closing of the pore being as protective as ischemic preconditioning.\ud Conclusion:\ud Inhibition of PKB plays a critical role in protection of the mammalian myocardium and may represent a clinical target for the reduction of ischaemic injury. Both formation and inhibition of the MPTP can be exploited for therapeutic purposes and that there is a defined therapeutic window, with the first few minutes of reoxygenation being a crucial period to achieve cardioprotection

Publisher: University of Leicester
Year: 2012
OAI identifier:

Suggested articles


  1. (2000). 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol Cell
  2. (2006). 3'Phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium.
  3. (1986). A biochemical and ultrastructural study on myocardial changes during aorto-coronary bypass surgery: St. Thomas Hospital cardioplegia versus intermittent aortic cross-clamping at 34 and 25 degrees C. Eur Surg Res
  4. (2001). A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus.
  5. (2004). Acetylcholine and bradykinin trigger preconditioning in the heart through a pathway that includes Akt and NOS. Am J Physiol Heart Circ Physiol
  6. (2001). Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation
  7. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell
  8. (2004). Akt stimulates aerobic glycolysis in cancer cells. Cancer Res
  9. (2007). AKT/PKB signaling: navigating downstream. Cell
  10. (1996). Apoptosis in pressure overload-induced heart hypertrophy in the rat.
  11. (2005). Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun
  12. (1996). Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest
  13. (2005). Autophagy in cardiac myocyte homeostasis, aging, and pathology. Cardiovasc Res
  14. Autophagy: molecular machinery for self-eating.
  15. (2007). Bongkrekic acid and atractyloside inhibits chloride channels from mitochondrial membranes of rat heart. Biochim Biophys Acta
  16. (1998). Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from
  17. (1998). Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells.
  18. (2006). Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning. Am J Physiol Heart Circ Physiol
  19. (1993). Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation
  20. (2005). Cardioprotective role of the mitochondrial ATPbinding cassette protein 1. Circ Res
  21. (2009). Cardioprotective signaling to mitochondria.
  22. (2000). Cardiopulmonary bypass exacerbates oxidative stress but does not increase proinflammatory cytokine release in patients with diabetes compared with patients without diabetes: regulatory effects of exogenous nitric oxide. J Thorac Cardiovasc Surg
  23. (2007). Caspases in cell survival, proliferation and differentiation. Cell Death Differ
  24. (1976). Cellular protection during myocardial ischemia: the development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation
  25. (2000). Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischaemia and reperfusion in man. Clin Sci (Lond)
  26. (2001). Combined and individual mitochondrial HSP60 and HSP10 expression in cardiac myocytes protects mitochondrial function and prevents apoptotic cell deaths induced by simulated ischemiareoxygenation. Circulation
  27. (1996). Comparative study of classical, colorimetric and immunologic staining methods for the assessment of tumor cell viability.
  28. (2008). Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels. Am J Physiol Heart Circ Physiol
  29. (1993). Contractile and vascular consequences of blood versus crystalloid cardioplegia in the isolated blood-perfused rat heart.
  30. (2004). Contribution of Akt and endothelial nitric oxide synthase to diazoxide-induced late preconditioning.
  31. (2005). Convergent signal transduction pathways controlling cardiomyocyte survival and function: the role of PI 3-kinase and Akt.
  32. (2004). Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc Res
  33. (2003). Deficiency of PDK1 in cardiac muscle results in heart failure and increased sensitivity to hypoxia.
  34. (1993). Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res
  35. (1988). Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone.
  36. (1999). Developments in cardioprotection: "polarized" arrest as an alternative to "depolarized" arrest. Ann Thorac Surg
  37. (2002). Different signaling pathways induce apoptosis in endothelial cells and cardiac myocytes during ischemia/reperfusion injury. Circ Res
  38. (1987). Direct measurement of free radical generation following reperfusion of ischemic myocardium.
  39. (1996). Direct preconditioning of cardiac ventricular myocytes via adenosine A1 receptor and KATP channel.
  40. (2008). Does inhibition of glycogen synthase kinase protect in mice? Circ Res
  41. (1995). Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res
  42. (2007). Effects of preconditioning and postconditioning on emergency percutaneous coronary intervention in patients with acute myocardial infarction. Zhonghua Yi Xue Za Zhi
  43. (1998). Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta
  44. (2009). Estrogen receptor beta mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia.
  45. (1987). Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria.
  46. (1996). Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation.
  47. (2001). Failure to precondition pathological human myocardium.
  48. (2002). FKHR-L1 can act as a critical effector of cell death induced by cytokine withdrawal: protein kinase B-enhanced cell survival through maintenance of mitochondrial integrity.
  49. (1986). Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis.
  50. (1993). Global myocardial ischemia protects the myocardium from subsequent regional ischemia. Cardioscience
  51. (2008). Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res
  52. (2008). Glycogen synthase kinase-3 inactivation is not required for ischemic preconditioning or postconditioning in the mouse. Circ Res
  53. (2006). Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell
  54. (2004). Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore.
  55. (2002). Goeddel DV. TNF-R1 signaling: a beautiful pathway. Science
  56. (1993). Halestrap AP. Protection by Cyclosporin A of ischemia/reperfusioninduced damage in isolated rat hearts.
  57. (1987). Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias.
  58. (1998). Human ventricular myocytes in vitro exhibit both early and delayed preconditioning responses to simulated ischemia.
  59. (2003). Identification of a proline-rich Akt substrate as a 14-3-3 binding partner.
  60. (2002). Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell
  61. (2005). Impairment of diazoxide-induced formation of reactive oxygen species and loss of cardioprotection in connexin 43 deficient mice. Circ Res
  62. (2005). Importance of the postdischarge interval in assessing major adverse clinical event rates following percutaneous coronary intervention.
  63. (2003). In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation.
  64. (2009). Inadvertent phosphorylation of survival kinases in isolated perfused hearts: a word of caution. Basic Res Cardiol
  65. (2003). Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res
  66. (1988). Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress.
  67. (2000). Inhibition of endogenous nitric oxide synthase potentiates ischemia-reperfusion-induced myocardial apoptosis via a caspase-3 dependent pathway. Cardiovasc Res
  68. (1995). Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature
  69. (2008). Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation
  70. (2007). Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice. Am J Physiol Heart Circ Physiol
  71. (2003). Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.
  72. (1999). Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation
  73. (1998). Insulin increases the association of Akt-2 with Glut4-containing vesicles.
  74. (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science
  75. (1984). Intermittent aortic cross-clamping versus St. Thomas' Hospital cardioplegia in extensive aorta-coronary bypass grafting. A randomized clinical study. J Thorac Cardiovasc Surg
  76. (2008). Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT.
  77. (2006). Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis? Cell Death Differ
  78. (2003). Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart.
  79. (1992). Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res
  80. (1998). Ischaemic preconditioning: present position and future directions. Cardiovasc Res
  81. (2009). Ischemic postconditioning in pigs: no causal role for RISK activation. Circ Res
  82. (2006). Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway. Cardiovasc Res
  83. (2000). Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res
  84. (2003). Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo.
  85. (2005). K(ATP) channels and preconditioning: a re-examination of the role of mitochondrial K(ATP) channels and an overview of alternative mechanisms.
  86. (1988). Kinetic evidence for a heart mitochondrial pore activated by Ca2+, inorganic phosphate and oxidative stress. A potential mechanism for mitochondrial dysfunction during cellular Ca2+ overload.
  87. (1995). Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs.
  88. (2002). Lethal toxin of Bacillus anthracis causes apoptosis of macrophages.
  89. (2005). Low-pressure reperfusion alters mitochondrial permeability transition.
  90. MAP kinase is a mediator of ischemic preconditioning in pigs. Cardiovasc Res
  91. (1989). Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion. Evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ Res
  92. (1990). Mechanism of myocardial "stunning". Circulation
  93. (2009). Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol
  94. (2001). Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ Res
  95. (2006). Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium. Cardiovasc Res
  96. (2006). Mitochondrial membrane permeability transition and cell death. Biochim Biophys Acta
  97. (1995). Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion.
  98. (2006). Mitochondrial permeability transition pore and postconditioning. Cardiovasc Res
  99. (2005). Mitochondrial permeability transition pore as a target for cardioprotection in the human heart.
  100. (2004). Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res
  101. (2006). Mitochondrial PKC epsilon and mitochondrial ATP-sensitive K+ channel copurify and coreconstitute to form a functioning signaling module in proteoliposomes. Circ Res
  102. (1987). Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma.
  103. (2002). Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res
  104. (2000). Myocardial K(ATP) channels in preconditioning. Circ Res
  105. (1975). Myocardial resistance and tolerance to ischemia: physiological and biochemical basis. J Cardiovasc Surg (Torino)
  106. (2006). N6-(3-iodobenzyl)-adenosine-5'-Nmethylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta. J Pharmacol Exp Ther
  107. (2003). Na+-K+--ATPase-mediated signal transduction: from protein interaction to cellular function. Mol Interv
  108. (2004). New directions for protecting the heart against ischaemiareperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res
  109. (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature
  110. (1999). NF-kappaB is a target of AKT
  111. (2003). Nitric oxide: NO apoptosis or turning it ON? Cell Death Differ
  112. (2009). No risk, no ... cardioprotection? A critical perspective. Cardiovasc Res
  113. (2007). Nonapoptotic functions of caspases: caspases as regulatory molecules for immunity and cell-fate determination. Trends Cell Biol
  114. (2006). Opening mitoKATP increases superoxide generation from complex I of the electron transport chain.
  115. (2000). Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals. Circ Res
  116. (2001). Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart.
  117. (2004). Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res
  118. (1997). Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation
  119. (2001). Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice.
  120. (2002). Pharmacological and ischemic preconditioning of the human myocardium: mitoK(ATP) channels are upstream and p38MAPK is downstream of PKC.
  121. (2008). Phosphatidylinositol 3-kinase gamma is a critical mediator of myocardial ischemic and adenosine-mediated preconditioning. Circ Res
  122. (1999). Phosphorylation and regulation of Raf by Akt (protein kinase B). Science
  123. (2004). Physiological functions of protein kinase B/Akt. Biochem Soc Trans
  124. (2002). PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning.
  125. (2008). PKB and the mitochondria: AKTing on apoptosis. Cell Signal
  126. (2004). PKC-epsilon is upstream and PKC-alpha is downstream of mitoKATP channels in the signal transduction pathway of ischemic preconditioning of human myocardium.
  127. plate reader (BioTek Instruments, model ELx800uv),
  128. (2005). Postconditioning-A new link in nature's armor against myocardial ischemia-reperfusion injury. Basic Res Cardiol
  129. (2007). Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. Cardiovasc Res
  130. (2007). Preconditioning and postconditioning: united at reperfusion. Pharmacol Ther
  131. (2001). Preconditioning attenuates apoptosis and necrosis: role of protein kinase C epsilon and -delta isoforms.
  132. (1997). Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C.
  133. (1994). Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res
  134. (2004). Preconditioning protects by inhibiting the mitochondrial permeability transition.
  135. (2000). Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection. Cardiovasc Res
  136. (1991). Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass. Ann Thorac Surg
  137. (2004). Protein kinase activation and myocardial ischemia/reperfusion injury. Cardiovasc Res
  138. (2006). Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.
  139. (1983). Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation
  140. (1998). Regulation of cell death protease caspase-9 by phosphorylation. Science
  141. (2006). Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. Biochim Biophys Acta
  142. (1994). Relative time-profiles for free radical trapping, coronary flow, enzyme leakage, arrhythmias, and function during myocardial reperfusion. Free Radic Biol Med
  143. (2000). release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes.
  144. (2010). Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet
  145. (1994). Reperfusion injury induces apoptosis in rabbit cardiomyocytes.
  146. (1999). Requirement for protein kinase C in reactive oxygen species-induced apoptosis of vascular smooth muscle cells. Circulation
  147. (1998). Resistance to myocardial infarction induced by heat stress and the effect of ATP-sensitive potassium channel blockade in the rat isolated heart.
  148. (1977). Reversible inhibition of adenine nucleotide translocation by long chain acyl-CoA esters in bovine heart mitochondria and inverted submitochondrial particles. Comparison with atractylate and bongkrekic acid.
  149. (2009). Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol
  150. (2004). Role of Akt signaling in mitochondrial survival pathway triggered by hypoxic preconditioning. Circulation
  151. Role of nitric oxide in the modulation of angiogenesis.
  152. (2002). Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site from cyclosporin A.
  153. (2003). Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKB beta.
  154. (2007). Signaling pathways in ischemic preconditioning. Heart Fail Rev
  155. (1999). Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation
  156. (2005). Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury.
  157. (2002). Survival factormediated BAD phosphorylation raises the mitochondrial threshold for apoptosis. Dev Cell
  158. (2006). Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen4-one in human cancer cells.
  159. (2011). Temperature preconditioning is optimal at 26 degrees C and confers additional protection to hypothermic cardioplegic ischemic arrest. Exp Biol Med (Maywood)
  160. (2005). The activation of Akt/PKB signaling pathway and cell survival.
  161. (1979). The Ca2+-induced membrane transition in mitochondria.
  162. (1979). The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys
  163. (1996). The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res Cardiol
  164. (2002). The identification of ATPcitrate lyase as a protein kinase B (Akt) substrate in primary adipocytes.
  165. (2004). The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation.
  166. (2008). The life of a cell: apoptosis regulation by the PI3K/PKB pathway.
  167. (2006). The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition.
  168. (1999). The mitochondrial permeability transition pore. Biochem Soc Symp
  169. (2009). The molecular composition of the mitochondrial permeability transition pore.
  170. The Na,K-ATPase receptor complex: its organization and membership.
  171. (2008). The paradigm of postconditioning to protect the heart.
  172. (2008). The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitors. Curr Cancer Drug Targets
  173. (1996). The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res
  174. (2002). The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning. Basic Res Cardiol
  175. (2009). The role of the mitochondrial permeability transition pore in heart disease. Biochim Biophys Acta
  176. The St. Thomas' hospital cardioplegic solution: a characterization in two species.
  177. (2006). TOR signaling in growth and metabolism. Cell
  178. (2004). Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection. Circulation
  179. (2009). Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol
  180. Use of spin traps in intact animals undergoing myocardial ischemia/reperfusion: a new approach to assessing the role of oxygen radicals in myocardial "stunning".
  181. (2006). VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol
  182. (2009). What is the mitochondrial permeability transition pore?

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.